We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QTEK
3926
DELISTED
QualTek Services Inc. Class A Common Stock
QTEK
$11K ﹤0.01%
25,700
+23,559
+1,100% +$27.1K
ABB
3927
DELISTED
ABB Ltd
ABB
$11K ﹤0.01%
376
-9,463
-96% -$275K
AUD
3928
DELISTED
Audacy, Inc.
AUD
$11K ﹤0.01%
47,874
+24,079
+101% +$7.58K
SDIG
3929
DELISTED
Stronghold Digital Mining, Inc. Class A Common Stock
SDIG
$11K ﹤0.01%
2,310
-950
-29% -$7.21K
PEAR
3930
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$11K ﹤0.01%
8,943
+2,157
+32% +$4.54K
LYLT
3931
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
$11K ﹤0.01%
4,366
-6,950
-61% -$11.9K
SRNE
3932
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$11K ﹤0.01%
13,492
-196,400
-94% -$261K
PONOU
3933
DELISTED
Pono Capital Corp Unit
PONOU
$11K ﹤0.01%
1,000
SPNE
3934
DELISTED
SeaSpine Holdings Corporation Common Stock
SPNE
$11K ﹤0.01%
1,215
-706
-37% -$4.75K
EMCF
3935
DELISTED
Emclaire Financial Corp
EMCF
$11K ﹤0.01%
361
+305
+545% +$9.71K
BSQR
3936
DELISTED
BSQUARE Corporation
BSQR
$11K ﹤0.01%
9,873
+521
+6% +$575
AC
3937
DELISTED
Associated Capital Group
AC
$10K ﹤0.01%
243
-77
-24% -$3.13K
ACRS icon
3938
Aclaris Therapeutics
ACRS
$851M
$10K ﹤0.01%
640
-7,291
-92% -$117K
ACT icon
3939
Enact Holdings
ACT
$6.87B
$10K ﹤0.01%
414
-1,511
-78% -$36.9K
ACWV icon
3940
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
$10K ﹤0.01%
+100
New +$9.38K
ADSE icon
3941
ADS-TEC Energy
ADSE
$878M
$10K ﹤0.01%
3,356
+1,727
+106% +$8.71K
AKBA icon
3942
Akebia Therapeutics
AKBA
$242M
$10K ﹤0.01%
17,211
-20,612
-54% -$6.46K
ALHC icon
3943
Alignment Healthcare
ALHC
$2.9B
$10K ﹤0.01%
842
-16,926
-95% -$206K
ALRM icon
3944
Alarm.com
ALRM
$2.73B
$10K ﹤0.01%
202
-4,871
-96% -$269K
ALRS icon
3945
Alerus Financial
ALRS
$838M
$10K ﹤0.01%
411
-1,099
-73% -$24.9K
ALZN icon
3946
Alzamend Neuro
ALZN
$7.43M
$10K ﹤0.01%
+13
New +$18.8K
APEI icon
3947
American Public Education
APEI
$828M
$10K ﹤0.01%
775
-920
-54% -$11.4K
ARKO icon
3948
ARKO Corp
ARKO
$544M
$10K ﹤0.01%
1,203
-8,739
-88% -$80.9K
BATL icon
3949
Battalion Oil
BATL
$30.4M
$10K ﹤0.01%
1,012
+162
+19% +$1.92K
BATRA icon
3950
Atlanta Braves Holdings Series A
BATRA
$3.68B
$10K ﹤0.01%
293
-908
-76% -$28.7K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.